EUVIMEDEUVIMED entdecken
Open Access

Repeated-Dose 28-Day Oral Toxicity Study of a Salmonella enterica Serovar Typhimurium Bacteriophage Cocktail (SE.PC) in BALB/c Mice

Yee Fan Tan iD, Prasanna Mutusamy, Sivachandran Parimannan, Heera Rajandas, Parasuraman Subramani

PHAGE: Therapy, Applications, and Research · 01.09.2026 · 7 (3) · 178-186

DOI: 10.1177/26416549261448405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PHAGE: Therapy, Applications, and Research, online erschienen am 02.05.2026. Verfasst von Yee Fan Tan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence for Omics-Driven Computational Biodiscovery (COMBio), AIMST University, Bedong, Kedah, Malaysia. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundamental Research Grant Scheme (FRGS) from the Ministry of Education (MOE) of Malaysia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Phage therapy is a promising alternative for drug-resistant Salmonella , but safety data for repeated doses are limited. This study investigated the sub-chronic safety of SE.PC, a candidate Salmonella enterica serovar Typhimurium phage cocktail, in a non-specific pathogen-free (non-SPF) model, which contains a naturally occurring microbiota, to evaluate systemic safety under physiologically relevant conditions. We tested a range of phage doses to determine if there are any differences in tolerance. Materials and Methods: During a 28-day repeated-dose oral toxicity study, SE.PC was administered via weekly gavage to male and female non-SPF BALB/c mice across three different phage doses (2.43 × 10 9 , 4.85 × 10 9 , and 9.70 × 10 9 plaque-forming units/mL). Clinical signs, body weight, hematology, biochemistry, and histopathology were assessed.

Results

Across all three administered phage dose groups, no mortality was recorded, and all mice exhibited normal clinical signs and growth. Hematological and biochemical values remained within baseline ranges. Histopathology revealed no treatment-related lesions; isolated findings were deemed incidental or adaptive.

Conclusion

Evidence supports that SE.PC is well tolerated. This study demonstrates a strong safety profile, supporting the advancement of SE.PC as a biocontrol agent.

Schlagwörter

Stichwörter der Autor:innen

Salmonella enterica serovar Typhimuriumantimicrobial resistancebacteriophage cocktailphage therapypreclinical safetyrepeated-dose toxicity

Autor:innen und Institutionen

  • Center of Excellence for Omics-Driven Computational Biodiscovery (COMBio), AIMST University, Bedong, Kedah, Malaysia.
  • Center for Evolutionary Hologenomics, Globe Institute, University of Copenhagen, Copenhagen, Denmark.
  • Pharmacology, Toxicology, and Basic Health Sciences Unit, AIMST University, Bedong, Kedah, Malaysia.

ORCID-Profile: Yee Fan Tan

Förderung

  • Fundamental Research Grant Scheme (FRGS) from the Ministry of Education (MOE) of Malaysia

Zitieren

APA

Tan, Y. F., Mutusamy, P., Parimannan, S., Rajandas, H., & Subramani, P. (2026). Repeated-Dose 28-Day Oral Toxicity Study of a Salmonella enterica Serovar Typhimurium Bacteriophage Cocktail (SE.PC) in BALB/c Mice. PHAGE: Therapy, Applications, and Research, 7(3), 178-186. https://doi.org/10.1177/26416549261448405

Vancouver

Tan YF, Mutusamy P, Parimannan S, Rajandas H, Subramani P. Repeated-Dose 28-Day Oral Toxicity Study of a Salmonella enterica Serovar Typhimurium Bacteriophage Cocktail (SE.PC) in BALB/c Mice. PHAGE: Therapy, Applications, and Research. 2026;7(3):178-186. doi:10.1177/26416549261448405

BibTeX
@article{Tan2026,
  author = {Tan, Yee Fan and Mutusamy, Prasanna and Parimannan, Sivachandran and Rajandas, Heera and Subramani, Parasuraman},
  title = {Repeated-Dose 28-Day Oral Toxicity Study of a Salmonella enterica Serovar Typhimurium Bacteriophage Cocktail (SE.PC) in BALB/c Mice},
  journal = {PHAGE: Therapy, Applications, and Research},
  year = {2026},
  volume = {7},
  number = {3},
  pages = {178--186},
  doi = {10.1177/26416549261448405}
}
Kostenlos starten →